Physician profile
Ryan Brenza
NPI 1356331854
$1,243.75
in general payments reported to CMS, 2019-2025
19 companies · $856 in 2025
The $856 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.70 · 2021: $321 · 2022: $43.89 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $365.30 | 2021-2022 | |
| Glaxosmithkline, LLC. | $127.37 | 2025 | Trelegy Ellipta |
| Medtronic, INC. | $105.41 | 2025 | Interstim |
| Amgen INC. | $102.59 | 2025 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $74.61 | 2025 | Airsupra |
| Exact Sciences Corporation | $72.11 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.55 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $56.63 | 2025 | |
| Astellas Pharma US INC | $45.94 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $41.00 | 2025 | Gemtesa |
| Abbott Laboratories | $33.46 | 2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $32.34 | 2025 | Kisunla, Jardiance |
| Sanofi Pasteur INC. | $22.70 | 2019 | |
| Merck Sharp & Dohme LLC | $21.75 | 2025 | Gardasil 9, Capvaxive |
| Novo Nordisk INC | $20.70 | 2025 | Ozempic, Rybelsus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $16.88 | 2025 | Voquezna |
| Smith+Nephew, INC. | $16.46 | 2025 | Collagenase Santyl |
| Globus Medical, INC. | $16.36 | 2025 | Senza |
| Pfizer INC. | $13.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Brenza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.